Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease
暂无分享,去创建一个
Jan Aasly | Ursula Sonnewald | L. White | J. Zwart | J. Aasly | U. Sonnewald | Ø. Nygaard | Øystein Nygaard | Mari Gårseth | Linda R. White | Marianne Rød | John‐Anker Zwart | M. Gårseth | M. Rød
[1] B. Rosen,et al. Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy , 1993, Neurology.
[2] O. Petroff,et al. High‐Resolution Proton Magnetic Resonance Analysis of Human Cerebrospinal Fluid , 1986, Journal of neurochemistry.
[3] P M Pattany,et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. , 1995, AJNR. American journal of neuroradiology.
[4] A. Schousboe,et al. First direct demonstration of preferential release of citrate from astrocytes using [13C]NMR spectroscopy of cultured neurons and astrocytes , 1991, Neuroscience Letters.
[5] P. Magistretti,et al. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Gebhardt,et al. Glycogen in astrocytes: possible function as lactate supply for neighboring cells , 1993, Brain Research.
[7] A Heerschap,et al. Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.
[8] J. Lindon,et al. 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. , 1993, Journal of pharmaceutical and biomedical analysis.
[9] Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid From Patients With Low Back Pain and Sciatica , 1997, Spine.
[10] L. White,et al. Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis , 1997, Acta neurologica Scandinavica.
[11] B D Ross,et al. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases , 1998, Neurology.
[12] A. Schousboe,et al. Trafficking between glia and neurons of TCA cycle intermediates and related metabolites , 1997, Glia.
[13] A. Schousboe,et al. Uptake, Release, and Metabolism of Citrate in Neurons and Astrocytes in Primary Cultures , 1994, Journal of neurochemistry.
[14] A. Schousboe,et al. 13C NMR spectroscopy study of cortical nerve cell cultures exposed to hypoxia , 1994, Journal of neuroscience research.
[15] C. Marsden,et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.
[16] H. Ågren,et al. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. , 1984, Biological psychiatry.
[17] S. Mukerji,et al. Lactate release from cultured astrocytes and neurons: A comparison , 1988, Glia.
[18] B. Hyman,et al. Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.
[19] J. Vion-Dury,et al. CSF and serum metabolic profile of patients with Huntington's chorea: A study by high resolution proton NMR spectroscopy and HPLC , 1993, Neuroscience Letters.
[20] A. Schousboe,et al. Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons , 1993, Neurochemistry International.
[21] B. Snow,et al. Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.
[22] A. Schousboe,et al. Citrate modulates the regulation by Zn2+ of N-methyl-D-aspartate receptor-mediated channel current and neurotransmitter release. , 1995, Proceedings of the National Academy of Sciences of the United States of America.